RECOMMENDATION REITERATED WANG LABS ltWANB Analyst Thomas McCrann Merrill Lynch reiterated buy recommendation Wang Laboratories Inc noting successful cost cutting campaign reduce earnings loss expected quarter ending March Wang actively traded stock American Stock Exchange rising 34 1658 McCrann Wang bit ahead expected cost reductions result odds increased loss quarter expected McCrann expects Wang report break earnings share small loss share quarter year however company report loss 50 cts share compared earnings 35 cts share year ago